{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:06:17Z","timestamp":1790805977811,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18am0301003h0005"],"award-info":[{"award-number":["18am0301003h0005"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["19ek0610013h0003"],"award-info":[{"award-number":["19ek0610013h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["20am0401006h0002"],"award-info":[{"award-number":["20am0401006h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.omtn.2022.05.006","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T21:00:25Z","timestamp":1651870825000},"page":"910-919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Systemic DNA\/RNA heteroduplex oligonucleotide administration for regulating the gene expression of dorsal root ganglion and sciatic nerve"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4272-6347","authenticated-orcid":false,"given":"Hidetoshi","family":"Kaburagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4111-2693","authenticated-orcid":false,"given":"Tetsuya","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6009-450X","authenticated-orcid":false,"given":"Masaki","family":"Ohyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2436-9588","authenticated-orcid":false,"given":"Kensuke","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kie","family":"Yoshida-Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoe","family":"Ebihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0548-4449","authenticated-orcid":false,"given":"Ken","family":"Asada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0227-8658","authenticated-orcid":false,"given":"Atsushi","family":"Okawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6490-3263","authenticated-orcid":false,"given":"Takanori","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2022.05.006_bib1","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2022.05.006_bib2","doi-asserted-by":"crossref","first-page":"eaan0713","DOI":"10.1126\/scitranslmed.aan0713","article-title":"Systemic administration of the antisense oligonucleotide NS-065\/NCNP-01 for skipping of exon 53 in patients with Duchenne muscular dystrophy","volume":"10","author":"Komaki","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2022.05.006_bib3","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.omtn.2018.09.017","article-title":"NS-065\/NCNP-01: an antisense oligonucleotide for potential treatment of exon 53 skipping in Duchenne muscular dystrophy","volume":"13","author":"Watanabe","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2022.05.006_bib4","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.23982","article-title":"Eteplirsen for the treatment of Duchenne muscular dystrophy","volume":"74","author":"Mendell","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2022.05.006_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2022.05.006_bib6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1474-4422(13)70061-9","article-title":"An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study","volume":"12","author":"Miller","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.omtn.2022.05.006_bib7","doi-asserted-by":"crossref","first-page":"eaag0481","DOI":"10.1126\/scitranslmed.aag0481","article-title":"Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy","volume":"9","author":"DeVos","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2022.05.006_bib8","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.omtn.2017.08.002","article-title":"LRRK2 antisense oligonucleotides ameliorate \u03b1-synuclein inclusion formation in a Parkinson's disease mouse model","volume":"8","author":"Zhao","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2022.05.006_bib9","doi-asserted-by":"crossref","first-page":"7969","DOI":"10.1038\/ncomms8969","article-title":"DNA\/RNA heteroduplex oligonucleotide for highly efficient gene silencing","volume":"6","author":"Nishina","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2022.05.006_bib10","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1038\/s41598-018-22577-2","article-title":"Modulation of blood-brain barrier function by a heteroduplex oligonucleotide in\u00a0vivo","volume":"8","author":"Kuwahara","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2022.05.006_bib11","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41587-021-00972-x","article-title":"Cholesterol-functionalized DNA\/RNA heteroduplexes cross the blood\u2013brain barrier and knock down genes in the rodent CNS","volume":"39","author":"Nagata","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2022.05.006_bib12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev.pharmtox.010909.105654","article-title":"RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform","volume":"50","author":"Bennett","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.omtn.2022.05.006_bib13","doi-asserted-by":"crossref","first-page":"17181","DOI":"10.1074\/jbc.M311683200","article-title":"Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs","volume":"279","author":"Wu","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2022.05.006_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/j.pain.0000000000001074","article-title":"Antisense oligonucleotides selectively suppress target RNA in nociceptive neurons of the pain system and can ameliorate mechanical pain","volume":"159","author":"Mohan","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.omtn.2022.05.006_bib15","doi-asserted-by":"crossref","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.omtn.2022.05.006_bib16","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","article-title":"Neuropathic pain in the general population: a systematic review of epidemiological studies","volume":"155","author":"van Hecke","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.omtn.2022.05.006_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/1871527315666161213104417","article-title":"Neuropathic pain and lung delivery of nanoparticulate drugs: an emerging novel therapeutic strategy","volume":"16","author":"Islam","year":"2017","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.omtn.2022.05.006_bib18","series-title":"Sensory Neurons: Diversity, Development, and Plasticity","article-title":"The organization of bio-chemically characterized sensory neurons","author":"Hunt SP","year":"1992"},{"key":"10.1016\/j.omtn.2022.05.006_bib19","series-title":"Morphological and Biochemical Cell Types of Sensory Neurons","author":"Lawson","year":"1992"},{"key":"10.1016\/j.omtn.2022.05.006_bib20","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1124\/dmd.106.012401","article-title":"Cross-species pharmacokinetic comparison from mouse to man of a second-generation antisense oligonucleotide, ISIS 301012, targeting human apolipoprotein B-100","volume":"35","author":"Yu","year":"2007","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.omtn.2022.05.006_bib21","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1517\/17425250902877680","article-title":"Antisense oligonucleotide pharmacokinetics and metabolism","volume":"5","author":"Geary","year":"2009","journal-title":"Expert. Opin. Drug. Metab. Toxicol."},{"key":"10.1016\/j.omtn.2022.05.006_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2147\/JPR.S26603","article-title":"Dorsal root ganglion \u2013 a potential new therapeutic target for neuropathic pain","volume":"5","author":"Sapunar","year":"2012","journal-title":"J.\u00a0Pain. Res."},{"key":"10.1016\/j.omtn.2022.05.006_bib23","doi-asserted-by":"crossref","first-page":"7640","DOI":"10.1073\/pnas.96.14.7640","article-title":"A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3\/SNS and NaN\/SNS2, in rat models of chronic pain","volume":"96","author":"Porreca","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U\u00a0S\u00a0A"},{"key":"10.1016\/j.omtn.2022.05.006_bib24","doi-asserted-by":"crossref","first-page":"e19865","DOI":"10.1371\/journal.pone.0019865","article-title":"Antisense-mediated knockdown of Na(V)1.8, but not Na(V)1.9, generates inhibitory effects on complete Freund's adjuvant-induced inflammatory pain in rat","volume":"6","author":"Yu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2022.05.006_bib25","doi-asserted-by":"crossref","first-page":"8139","DOI":"10.1523\/JNEUROSCI.22-18-08139.2002","article-title":"Functional downregulation of P2X3 receptor subunit in rat sensory neurons reveals a significant role in chronic neuropathic and inflammatory pain","volume":"22","author":"Barclay","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtn.2022.05.006_bib26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/WNR.0b013e32833774bf","article-title":"Role of spinal p38\u03b1 and \u03b2 MAPK in inflammatory hyperalgesia and spinal COX-2 expression","volume":"21","author":"Fitzsimmons","year":"2010","journal-title":"Neuroreport"},{"key":"10.1016\/j.omtn.2022.05.006_bib27","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1523\/JNEUROSCI.0300-04.2004","article-title":"Altered sodium channel expression in second-order spinal sensory neurons contributes to pain after peripheral nerve injury","volume":"24","author":"Hains","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtn.2022.05.006_bib28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0304-3959(01)00391-8","article-title":"Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1.8","volume":"95","author":"Lai","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.omtn.2022.05.006_bib29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pain.2005.05.027","article-title":"Relationship between sodium channel NaV1.3 expression and neuropathic pain behavior in rats","volume":"117","author":"Lindia","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.omtn.2022.05.006_bib30","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/j.1471-4159.2004.02996.x","article-title":"Spinal p38\u03b2 isoform mediates tissue injury-induced hyperalgesia and spinal sensitization","volume":"92","author":"Svensson","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.omtn.2022.05.006_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.celrep.2012.06.003","article-title":"The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult","volume":"2","author":"Zhang","year":"2012","journal-title":"Cell. Rep."},{"key":"10.1016\/j.omtn.2022.05.006_bib32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-physiol-021317-121550","article-title":"SR-B1: a unique multifunctional receptor for cholesterol influx and efflux","volume":"80","author":"Shen","year":"2018","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.omtn.2022.05.006_bib33","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/nat.2013.0443","article-title":"Characterization of target mRNA reduction through in\u00a0situ RNA hybridization in multiple organ systems following systemic antisense treatment in animals","volume":"23","author":"Hung","year":"2013","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.omtn.2022.05.006_bib34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1124\/jpet.115.226969","article-title":"Identification and characterization of modified antisense oligonucleotides targeting DMPK in mice and nonhuman primates for the treatment of myotonic dystrophy type 1","volume":"355","author":"Pandey","year":"2015","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.omtn.2022.05.006_bib35","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1093\/hmg\/ddw266","article-title":"Dmpk gene deletion or antisense knockdown does not compromise cardiac or skeletal muscle function in mice","volume":"25","author":"Carrell","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2022.05.006_bib36","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","article-title":"Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis","volume":"74","author":"Kordasiewicz","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.omtn.2022.05.006_bib37","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00684815","article-title":"A study of the perineurial diffusion barrier of a peripheral ganglion","volume":"46","author":"Arvidson","year":"1979","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.omtn.2022.05.006_bib38","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/00000542-200607000-00024","article-title":"Permeability of injured and intact peripheral nerves and dorsal root ganglia","volume":"105","author":"Abram","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.omtn.2022.05.006_bib39","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3390\/ijms21010270","article-title":"Regional differences in tight junction protein expression in the blood-DRG barrier and their alterations after nerve traumatic injury in rats","volume":"21","author":"Lux","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2022.05.006_bib40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00688950","article-title":"The mouse blood-brain barrier and blood-nerve barrier for IgG: a tracer study by use of the avidin-biotin system","volume":"68","author":"Seitz","year":"1985","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.omtn.2022.05.006_bib41","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/BF00687487","article-title":"Studies on vascular permeability in peripheral nerves","volume":"17","author":"Olsson","year":"1971","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.omtn.2022.05.006_bib42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0022-510X(76)90083-6","article-title":"Vascular leakage in the dorsal root ganglia of the rat, studied with horseradish peroxidase","volume":"29","author":"Jacobs","year":"1976","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.omtn.2022.05.006_bib43","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0022-2275(20)41390-2","article-title":"Effects of apolipoprotein E, beta-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in\u00a0vitro","volume":"33","author":"Handelmann","year":"1992","journal-title":"J.\u00a0Lipid. Res."},{"key":"10.1016\/j.omtn.2022.05.006_bib44","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/j.1471-4159.1991.tb06417.x","article-title":"Uptake of endoneurial lipoprotein into schwann cells and sensory neurons is mediated by low density lipoprotein receptors and stimulated after axonal injury","volume":"57","author":"Rothe","year":"1991","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.omtn.2022.05.006_bib45","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.mam.2007.01.002","article-title":"Absorption, transport, and tissue delivery of vitamin E","volume":"28","author":"Rigotti","year":"2007","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.omtn.2022.05.006_bib46","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1124\/jpet.113.212407","article-title":"Pharmacology of a central nervous system delivered 2'-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primates","volume":"350","author":"Rigo","year":"2014","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.omtn.2022.05.006_bib47","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.nbd.2018.03.002","article-title":"Antisense-mediated reduction of EphA4 in the adult CNS does not improve the function of mice with amyotrophic lateral sclerosis","volume":"114","author":"Ling","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omtn.2022.05.006_bib48","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.omtn.2022.05.006_bib49","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jconrel.2018.05.010","article-title":"Angubindin-1 opens the blood-brain barrier in\u00a0vivo for delivery of antisense oligonucleotide to the central nervous system","volume":"283","author":"Zeniya","year":"2018","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.omtn.2022.05.006_bib50","doi-asserted-by":"crossref","first-page":"e7383","DOI":"10.1371\/journal.pone.0007383","article-title":"The contribution of TRPM8 and TRPA1 channels to cold allodynia and neuropathic pain","volume":"4","author":"Caspani","year":"2009","journal-title":"PLoS One"}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253122001196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253122001196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:29:13Z","timestamp":1761874153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253122001196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":50,"alternative-id":["S2162253122001196"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2022.05.006","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic DNA\/RNA heteroduplex oligonucleotide administration for regulating the gene expression of dorsal root ganglion and sciatic nerve","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2022.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors.","name":"copyright","label":"Copyright"}]}}